Task: Answer Verification
Input (English): Question: Does homocysteine-lowering therapy affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease?
Answer: In patients with stable CAD, homocysteine-lowering therapy with B-vitamins does not affect levels of inflammatory markers associated with atherogenesis. Failure to reverse inflammatory processes, may partly explain the negative results in clinical secondary B-vitamin intervention trials.
Output (English): no